Sponsored Links

Risk Of Leukemia With Multiple Sclerosis Drug Higher Than Thought PDF Print E-mail
Medical News - Lymphoma and Leukemia
The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 - May 2, 2009. Mitoxantrone is an immunosuppressant drug approved by the FDA for treatment of several forms of advancing MS.

Read more: Lymphoma / Leukemia News From Medical News Today